Skip to content
FuturNet Communication logo — La vision du futur

FuturNet Communication

La vision du futur

Founded 2008 United Kingdom Nottingham, United Kingdom 1 employees Venture round Total: $3.90M Biopharma, Biotechnology

General Information

Company Name FuturNet Communication
Founded Year 2008
Location United Kingdom Nottingham, United Kingdom
Employees 1
Industries Biopharma, Biotechnology
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with FuturNet Communication. To contact FuturNet Communication, visit futurnet.artisteer.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FuturNet Communication compare?

A PDF of FuturNet Communication and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FuturNet Communication soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FuturNet Communication

CompanDx Ltd is a Biopharma and Biotechnology company founded in 2008 and headquartered in the United Kingdom. The company specializes in unlocking the secrets of personalized medicine by leveraging in-house data analysis algorithms to identify patterns in healthcare data sets. CompanDx applies its technology to clinical trial and medical sample data to discover new disease markers, focusing on the identification of novel biomarkers accompanying the use of targeted therapies and companion diagnostics. The systematic application of technologies and mass spectrometry combined with Bioinformatics has enabled CompanDx to identify disease-specific biomarkers. The company also provides data mining services to proprietary repositories and monitors complete analysis of clinical trial databases. This focus is aimed at enabling effective disease management and reducing the risk of trial failure by patient stratification. CompanDx secured a £3.90M Venture Round investment on 31 July 2012. The investors involved in the last investment round are not specified. The company’s commitment to leveraging advanced technologies for personalized medicine and clinical trial analysis positions it as an innovative player in the biopharma and biotechnology sectors.

Business keywords: personalized medicine, healthcare data, clinical trials, medical samples, biomarkers, targeted therapies, companion diagnostics, data mining, mass spectrometry, bioinformatics, patient stratification, disease management, trial failure, proprietary repositories

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £3.90M -
31 Jul 2012

FuturNet Communication Alternatives & Competitors

View All Alternatives
FuturNet Communication vs
PhiTech
PhiTech Turkey

Multi-omics AI for Precision Medicine

27 employees
Biopharma, Biotechnology
FuturNet Communication vs

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Post-IPO Secondary
33 employees
AI, Biopharma
FuturNet Communication vs
Sano Genetics
Sano Genetics United Kingdom

Accelerating the world's transition to precision medicine.

50 employees
Biopharma, Biotechnology

FAQ About FuturNet Communication

La vision du futur
FuturNet Communication was founded in 2008.
FuturNet Communication is headquartered in Nottingham, United Kingdom.
FuturNet Communication operates in Biopharma and Biotechnology. Its work centres on personalized medicine, healthcare data, clinical trials and medical samples.
FuturNet Communication has approximately 1 employees.
FuturNet Communication has completed 1 funding round, raising a total of $3.90M. The latest funding stage is Venture round.
Top alternatives and competitors to FuturNet Communication include PhiTech, Lantern Pharma Inc. (Nasdaq: LTRN), Sano Genetics, KYAN Therapeutics, OASYS NOW. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FuturNet Communication and PhiTech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FuturNet Communication, https://www.bouncewatch.com/company/compandx-ltd, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout